JCGI vs. USA, AGT.LN, MRCH, JESC, BBH, BGSC, NBPE, SLS, ESCT, and TRG
Should you be buying JPMorgan China Growth & Income stock or one of its competitors? The main competitors of JPMorgan China Growth & Income include Baillie Gifford US Growth (USA), AVI Global Trust (AGT.LN), The Merchants Trust (MRCH), JPMorgan European Smaller Companies Trust (JESC), Bellevue Healthcare (BBH), BMO Global Smaller Companies (BGSC), NB Private Equity Partners (NBPE), Standard Life UK Smaller Companies Trust (SLS), The European Smaller Companies Trust (ESCT), and The European Smaller Companies Trust (TRG). These companies are all part of the "asset management" industry.
JPMorgan China Growth & Income vs.
JPMorgan China Growth & Income (LON:JCGI) and Baillie Gifford US Growth (LON:USA) are both small-cap financial services companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, community ranking, earnings, valuation and media sentiment.
23.0% of JPMorgan China Growth & Income shares are owned by institutional investors. Comparatively, 38.8% of Baillie Gifford US Growth shares are owned by institutional investors. 1.2% of JPMorgan China Growth & Income shares are owned by company insiders. Comparatively, 1.4% of Baillie Gifford US Growth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Baillie Gifford US Growth received 1 more outperform votes than JPMorgan China Growth & Income when rated by MarketBeat users.
Baillie Gifford US Growth has higher revenue and earnings than JPMorgan China Growth & Income. Baillie Gifford US Growth is trading at a lower price-to-earnings ratio than JPMorgan China Growth & Income, indicating that it is currently the more affordable of the two stocks.
In the previous week, JPMorgan China Growth & Income had 1 more articles in the media than Baillie Gifford US Growth. MarketBeat recorded 1 mentions for JPMorgan China Growth & Income and 0 mentions for Baillie Gifford US Growth. JPMorgan China Growth & Income's average media sentiment score of 1.55 beat Baillie Gifford US Growth's score of 0.00 indicating that JPMorgan China Growth & Income is being referred to more favorably in the media.
Baillie Gifford US Growth has a net margin of 93.74% compared to JPMorgan China Growth & Income's net margin of 72.25%. Baillie Gifford US Growth's return on equity of 14.55% beat JPMorgan China Growth & Income's return on equity.
Summary
Baillie Gifford US Growth beats JPMorgan China Growth & Income on 9 of the 13 factors compared between the two stocks.
Get JPMorgan China Growth & Income News Delivered to You Automatically
Sign up to receive the latest news and ratings for JCGI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
JPMorgan China Growth & Income Competitors List
Related Companies and Tools
This page (LON:JCGI) was last updated on 2/23/2025 by MarketBeat.com Staff
Free JCGI Stock Alerts